GATA2 and Immunodeficiency: Although immunodeficiency represents one of the main features of the clinical picture, the high risk of developing myeloid neoplasms is the main sword hanging over the head of patients with GATA2 deficiency, presenting in more than 80% of patients by the age of 40 (41).